BrainsWay (XTAE:BWAY) Short Interest


XTAE:BWAY BrainsWay Ltd XTAE:BWAY
70 GF Score
Price ₪47.50
GF Value ₪21.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is BrainsWay Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XTAE:BWAY vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, BrainsWay's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BrainsWay Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BrainsWay's Short Interest distribution charts can be found below:

* The bar in red indicates where BrainsWay's Short Interest falls into.


XTAE:BWAY
70GF Score
BrainsWay Ltd XTAE:BWAY
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BrainsWay (XTAE:BWAY) Overvalued in 2026?

Based on GuruFocus' analysis, BrainsWay stock appears to be overvalued. The current stock price of ₪47.50 is trading 116% above its estimated GF Value™ of ₪21.99. GuruFocus considers BrainsWay to be Significantly Overvalued.

Key valuation signals for XTAE:BWAY:

  • Short Interest:
  • GF Value™: ₪21.99 vs. price of ₪47.50 (116% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the XTAE:BWAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BrainsWay Business Description

Other Exchanges BWAY:USA
Address 16 Hartum Street, 14th Floor, RAD Tower, Har HaHotzvim, Jerusalem, ISR, 9777516
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
70GF Score

Get the complete analysis for XTAE:BWAY

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪47.50
Price
₪21.99
GF Value